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Neutrophils play a basic role in host defense against 
infection and any decrease in their functional 
capability adds to high susceptibility and 
seriousness of infection1. Abnormalities in 
granulocyte chemotaxis, phagocytosis and anti-
microbial activity have been described in 
experimental studies on diabetic rats and mice and 
clinical investigations of diabetic patients1. During 
the neonatal period, response against infections 
mainly depends on the innate immunity and any 
impairment of innate immunity during the 
intrauterine life may decrease microbicidal 
activities2. Gestational diabetes mellitus is 
associated with down regulation of the placental 
inflammatory response affecting nutrient 
transporter expression and activity. These changes 
in placental function may be the cause of reduced 
cell-mediated immunity and lower chemotactic 
activity of cord blood neutrophils from infants of 
diabetic mothers3.  Previous studies have addressed 
the deleterious effect of diabetes on patients’ 
neutrophils functions, and neutrophil functional 
activity in neonates born to mothers with 
gestational diabetes4. In our study we focused on 
changes in the neutrophil chemotactic and 
phagocytic activities of neonates due to maternal 
gestational diabetes. Furthermore, we addressed 
only those who have been following up regularly 
and controlled on insulin to exclude any bias that 






This was a cross-sectional controlled study 
performed over 6 months, on 45 full term neonates 
delivered at Ain Shams university neonatology 
units in 2014. 
Study group (Neonates of gestational diabetes 
mothers (NGDMs): included 30 full term neonates 
(38-40 weeks) born to mothers with gestational 
diabetes mellitus recruited at delivery (NGDMs).  
All women who were followed up regularly during 
pregnancy at the Ain shams University obstetrics 
clinic and who had their blood glucose levels 
controlled on insulin therapy without other diabetes 
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comorbidities or complications were candidates for 
inclusion in the study. The mother was approached 
and informed consent was obtained. Eligible 
women had to be admitted at least 2 hours before 
delivery to allow time for enrollment 
Control group:  included 15 sex and age 
matched apparently healthy full-term neonates 
recruited   on their 1st day of life. 
Exclusion criteria:  
• Any newborns with history suggestive of 
respiratory distress syndrome, neonatal sepsis or 
family history of immune deficiency. 
• Newborns with major congenital anomalies or 
multiple gestations.  
• Neonates born to mothers suffering from long 
standing diabetes mellitus or its microvascular 
complications and comorbidities. 
 
Methods  
All enrolled neonates were subjected to history 
taking and clinical examination (gestational age, 
birth weight, organomegaly and vital data). 
Laboratory investigations: 
Random blood sugar (RBS)) for assessment of any 
hypoglycemia at delivery where neonatal 
hypoglycemia was defined as a plasma glucose 
level of less than 30 mg/dL (1.65 mmol/L) in the 
first 24 hours of life and less than 45 mg/dL (2.5 
mmol/L) thereafter5. 
Verbal consents and approval were obtained 
from the parents after explanation of the subject and 
procedure. 
Sampling: 
a) Two mL cord blood (CB) samples were obtained 
from all enrolled subjects on ethylenediamine 
tetra-acetic acid, dipotassium salt (K2-EDTA) in 
vacutainer tubes (final concentration of 1.5 
mg/mL) for CBC and flow cytometric assays. 
b) Two mL PB samples were obtained on K2-
EDTA in vacutainer tubes from controls for flow 
cytometric assay. 
1) Complete blood counts (CBC) on Coulter 
LH750 cell counter (Coulter, Electronics, 
Hialeah, FL, USA) with examination of cord 
blood (CB) smears stained with Leishman stain 
and differential white cell count with emphasis 
on absolute neutrophilic count.  
2) Flow cytometric assay of oxidative burst using 
DHR 123: 
• Blood samples were processed on the same 
day of sample collection.  
• The reagents in this test are the 
dihydrorhodamine123 (DHR123) and 
phorbol 12-myristate 13-acetate (PMA) (both 
supplied from Sigma-Aldrich, St Louis, 
MO).  In making stock solutions, these 
reagents are diluted to 2500 µg/ml and 100 
µg/ml, respectively, in dimethyl sulfoxide 
(DMSO).  These stocks are then aliquoted 
and stored at -20oC until use. 
• Three tubes are set up for each patient and 
control: 
1. Blood only. 
2. Blood + DHR123 (Resting tube). 
3. Blood + DHR123 + PMA (Stimulated 
tube). 
• To all tubes 100 µl of blood is diluted 1:10 
with phosphate buffered saline with azide 
(PBA).  25 µl of thawed and diluted DHR123 
is added to tubes 2 and 3.  All tubes are 
incubated in a 37 degrees C water bath for 15 
minutes. Following this incubation, 100ul of 
the prepared PMA solution is added to tube 3 
and all tubes are incubated an additional 15 
minutes at 37 degrees C.  This step allows the 
neutrophils to be stimulated to undergo the 
oxidative burst thereby oxidizing the 
DHR123 to its resonance form (rhodamine) 
which is highly green fluorescent when 
exposed to the 488-nm laser.  After washing 
and centrifugation, the samples are lysed with 
ammonium chloride-based erythrocyte lysing 
solution (Pharm Lyse, Becton Dickinson, 
Mountainview, CA) for 10 minutes in the 
dark, followed by centrifugation and washing 
by PBS.   
• Tubes were vortexed then analyzed using the 
488nm laser and the FITC filter set up using 
Coulter Epics XL flow cytometer (Coulter, 
Electronics, Hialeah, FL, USA). 
Fluorescence is quantitated by mean peak 
channel fluorescence (MPC-FL). 
• Interpretation: 
Results are expressed as neutrophil oxidative 
index (NOI) which is the ratio of MPC-FL 
(PMA stimulated) over MPC-FL 
(unstimulated). 
3) Flow cytometric immunophenotyping of CD11b 
(Integrin α M) and CD62L (L-selectin) on 
neutrophils: 
• Anti-human CD11b phycoerythrin (PE) 
labeled and CD62L fluorescein 
isothiocyanate (FITC) labeled monoclonal 
antibodies were used in this study (both were 
supplied by R & D systems, Minneapolis, 
MN, USA). 
• CB samples were processed on the same day 
of sample collection. They are counted using 
Coulter Cell Counter and the total leucocytic 
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count was adjusted to be around 5.0 x 109/L 
using phosphate buffered saline (PBS).  
• 100 μL of adjusted sample were aliquoted in 
the control tube as well as each sample tube 
and then 20μL of each monoclonal antibody 
were added.  
• The test tubes were incubated for 15 minutes 
at room temperature, protected from light. 
• After incubation, 1-2 mL of ammonium 
chloride-based erythrocyte lysing solution 
were added to every tube. Tubes were 
vortexed then analyzed using Coulter Epics 
XL flow cytometer (Coulter, Electronics, 
Hialeah, FL, USA). 
 
Statistical methods: 
The collected data were collected and analyzed 
using statistical package for social science (SPSS) 
version for windows (version 15.0.1). All data were 
expressed as mean values ± SD. Comparisons of 
parameters among groups were made using paired t 
test. Comparisons between two qualitative variables 
were performed using chi-square and fisher’s exact 
tests. A p value ≤ 0.05 was considered significant  
 
RESULTS 
Neonates of gestational diabetes mothers 
(NGDMs) (n= 30) were compared to control 
neonates (n=15) by gestational age, sex, birth 
weight, length, mode of delivery and Apgar score 
(shown in Table 1). We did not report any case of 
hypoglycemia at time of sample withdrawal after 
birth in both groups. Comparative parameters of the 
CBC results between the two groups showed that 
NGDMs had significant lower mean total 
leucocytic and neutrophil counts (13.55±2.51 and 
9.01±1.59 respectively) than those of controls 
(17.89±3.66 and 14.18±3.44 respectively) P<0.001. 
The tested parameters of the neutrophil functions 
(DHR, CD11b, and CD62L) were significantly 
reduced in the NGDMs than controls as in table 2. 
A positive correlation was found between DHR and 
CD11b in neonates of gestational diabetic mothers 
in contrast to the control group where those 
parameters were negatively correlated (table 3, 4 
and figures 1and 2). 
 
Table 1. Demographic data of the studied groups 
 
 NGDMs (n=30) Control (n=15) Chi-square 
 N % N % X2 P-value 
Sex 
Female 10 33.3 4 26.7 
1.392 0.499 
Male 20 66.7 11 73.3 
Mode of delivery 
Normal 7 23.3 11 73.3 
10.417 <0.001* 
Cesarean 23 76.7 4 26.7 
Apgar score 1min. 
Range 8-10 8-10 
0.007 0.993 
Mean± SD 9.23±0.86 9.27±0.88 
Apgar score 5min. 
Range 10-10 6-10 
2.907 0.066 
Mean± SD 10.00±0.00 9.53±1.06 
Weight (Kg) 
Range 2.6-4.5 2.4-3.6 
0.141 0.869 
Mean± SD 3.26±0.37 3.20±0.32 
Length (cm) 
Range 48-60 36-55 
6.220 0.004* 
Mean± SD 51.53±2.43 46.93±6.23 
 * Statistically significant 
 
 
Table 2. Comparison between the studied groups as regard CBC DHR, CD11b, CD62L. 
 
 
IDMS Infant Anova test 
Mean SD Mean SD f P-value Sig. 
DHR 68.71 10.24 79.57 8.64 38.497 <0.001* HS 
CD11b 82.48 8.09 87.85 4.87 33.588 <0.001* HS 
CD62L 8.63 4.41 24.98 10.47 861.035 <0.001 HS 
DHR= dihydrorhodamine 123, CD62L = L selectin  
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r P-value r P-value 
CD 11b 0.390 0.033*   
























Table 4. Correlation between DHR & CD11b and CD11b & CD62L in control. 
 
control 
DHR CD 11b 
r P-value r P-value 
CD 11b -0.518 0.048   






Figure 2. Negative correlation between DHR and CD11b in control infants (r=-0.518/ P = 0.048) 
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DISCUSSION 
Neutrophils act as first-line-of-defense cells and the 
alteration of their functional activity contributes to 
high susceptibility and severity of infections1. 
During the neonatal period, the defense against 
infection is mainly dependent on innate immunity6. 
We assumed that gestational diabetes may affect the 
neutrophil function of the newborns affecting their 
innate immunity and defense mechanisms against 
infections. 
Our data indicate that the maternal gestational 
diabetes is accompanied by impairment of cord 
blood neutrophil function represented in relative 
lower levels of DHR, CD11b, and CD62L in 
neonates of gestational diabetic mothers than their 
matched controls. 
Normal pregnancy is associated with highly 
regulated inflammatory response that is vital to the 
process of placentation, from implantation through 
to labor at term7. Maternal gestational diabetes has 
been associated with altered inflammatory profiles 
in the mother, placenta and fetus leading to the co-
morbidities observed in these pregnancies. 
Vascular, endothelial changes, oxidative stress and 
tissue damage do occur in response to 
inflammation. Intrauterine inflammatory response 
evokes remarkable changes in development of 
microvessels, hematogenous cells and other 
components8. During inflammatory response, 
leucocytes roll along the lining endothelium of post 
capillary venules and eventually become attached to 
the vascular wall before migrating into tissue9. This 
may explain the relative leucopenia and neutropenia 
in IDM in comparison to controls.  
The finding that hemoglobin and hematocrit  in 
neonates of gestational diabetes mothers is higher 
than those in controls as well as their positive 
correlation with the CD62 level and negative 
correlation with the CD11b is consistent with the 
effect of relative hypoxia and peroxidation effect of 
high placental level of glucose during pregnancy on 
the red blood cell lipid membrane together with the 
protein synthesis, microtubular, cell membrane 
depolarization and microtubular structure of 
neutrophils10. 
We have demonstrated that neonates of 
gestational diabetes mothers have lower cord blood 
expression of CD11b, CD62L (L selectin) and DHR 
and that they are positively correlated to each other. 
Adhesion molecules such as CD11b and CD62L are 
important for rolling and adhesion as well as useful 
markers of neutrophil activation11. It has been found 
that neonatal neutrophils have lower functional 
adherence to the activated endothelium compared 
with those of adults12. This has been proved in 
many studies by finding defective expression and 
storage of CD18/CD11b and lower functional 
expression of CD11b on neonatal neutrophils13. In 
addition, Koeing etal14 correlated the defect in 
neutrophils' endothelial adherence to the diminished 
total cellular CD11b on neonatal neutrophils14. 
Moreover, maternal diabetes creates pro-
inflammatory placental environment, thus 
potentially influences the immune regulatory 
process of the neonates. In this context, deficiencies 
in neutrophil functions have been described in 
diabetic host 8. It has been proven by murine 
experimental models that diabetic mice are at 
higher risk of bacterial infections 15. Furthermore, 
studies showed that failure of neutrophil migration 
to infection sites is associated with poor outcome in 
experimental sepsis16. 
 L-selectin (CD62L), is a cell adhesion 
molecule found on lymphocytes and the 
preimplantation embryo. It is a marker of neutrophil 
activation and an important mediator of neutrophil 
rolling and adhesion to activated endothelium17. 
 Our results demonstrated that neutrophils from 
neonates of gestational diabetic mothers had a 
significant lower CD62L compared with control 
neonates. In Patients with diabetic microangiopathy 
were shown to have a significant decrease in 
surface CD62L expression. Changes in adhesion 
molecule expression also could contribute to the 
impairment of rolling and adhesion of leukocytes to 
endothelial cells found in diabetic mothers that may 
affect also their neonates18. 
DHR is a measure of neutrophil oxidative burst 
pathway and capability of superoxide production 
necessary for intracellular killing of catalase 
positive organisms19. Our data showed significantly 
lower mean values of DHR in NGDMs compared to 
control neonates. Studies have reported that DHR is 
higher in adult than in infant especially NGDMs20, 
21.  As previously known, microbicidal response of 
human neutrophils lies on the generation of reactive 
oxygen species (ROS) and activation of NADPH 
dependent oxidase releasing enzymatic and 
antimicrobial protein contents in the granules. Such 
responses are triggered by numerous agonists 
promoting adhesion or by phagocytic targets and as 
both are impaired during neonatal period this 
contributes to newborn incapability to generate O2 
in response to neutrophils stimulation and adds to 
increase susceptibility to infection22.   
We conclude that even controlled gestational 
diabetes without complications is still a risk factor 
for impaired neutrophil function in term neonates. 
This may be based on pathophysiology of the 
disease itself rather than the type of treatment or 
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blood glucose control during pregnancy. Further 
studies could address the effect of impaired glucose 
control during pregnancy on the neutrophil activity.  
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